CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Medical Devices (6162) Eye Health (703)
Glaukos (NYSE: GKOS) is an ophthalmic medical technology company focused on the development and commercialization of products and procedures to transform the treatment of glaucoma, one of the leading causes of blindness. Glaukos developed Micro-Invas...Show all
Company (IPO / Went public)
Phone: 949-367-9600
229 Avenida Fabricante
San Clemente, 92672
California, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Glaukos | $124M | Nov 1, 2017 |
| CytImmune Sciences | $10.4M | Apr 27, 2020 |
| Ren Pharmaceuticals | $1.5M | Jun 6, 2008 |
| See all 14 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Uveoscleral shunt and methods for implanting same | Aug 12, 2013 | May 08, 2018 | Patent |
| Shunt device and method for treating ocular disorders | Nov 11, 2016 | Nov 28, 2017 | Patent |
| Intraocular physiological sensor | Mar 13, 2013 | Aug 15, 2017 | Patent |
| Devices and methods for glaucoma treatment | Aug 08, 2007 | Mar 21, 2017 | Patent |
| Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye | Mar 11, 2014 | Mar 14, 2017 | Patent |
